Lingua: Inglese
Editore: Cambridge University Press, 1993
ISBN 10: 0521447887 ISBN 13: 9780521447881
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Cambridge University Press, 1993
ISBN 10: 0521447887 ISBN 13: 9780521447881
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: University of Massachusetts Press, 2001
ISBN 10: 1558493115 ISBN 13: 9781558493117
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Cambridge University Press, 1993
ISBN 10: 0521447887 ISBN 13: 9780521447881
Da: World of Books (was SecondSale), Montgomery, IL, U.S.A.
Condizione: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.
Lingua: Inglese
Editore: Cambridge University Press, 1992
ISBN 10: 0521394198 ISBN 13: 9780521394192
Da: AwesomeBooks, Wallingford, Regno Unito
EUR 6,07
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Very Good. Business Organization and the Myth of the Market Economy This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping.
Soft cover. Condizione: Near Fine. Capital. This is a clean, unmarked, undamaged copy.
Lingua: Inglese
Editore: Cambridge University Press, 1992
ISBN 10: 0521394198 ISBN 13: 9780521394192
Da: Midtown Scholar Bookstore, Harrisburg, PA, U.S.A.
hardcover. Condizione: Very Good. With very good dust jacket. Very Good hardcover with light shelfwear - NICE! Standard-sized.
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Cambridge University Press, 1992
ISBN 10: 0521394198 ISBN 13: 9780521394192
Da: Anybook.com, Lincoln, Regno Unito
EUR 7,34
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Poor. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Book contains pen markings. In poor condition, suitable as a reading copy. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,750grams, ISBN:0521394198.
Lingua: Inglese
Editore: University of Massachusetts, 2001
ISBN 10: 1558493115 ISBN 13: 9781558493117
Da: Robinson Street Books, IOBA, Binghamton, NY, U.S.A.
Membro dell'associazione: IOBA
Paperback. Condizione: Good. Prompt Shipment, shipped in Boxes, Tracking PROVIDEDOrganization & Management Of Education; Good trade paperback with clean pages, tips bumped, dog-eared, nicked, creasing, and prompt shipping with tracking.
EUR 13,25
Quantità: 1 disponibili
Aggiungi al carrelloSoft cover. Condizione: Near Fine.
Lingua: Inglese
Editore: Cambridge University Press, GB, 2022
ISBN 10: 1009278169 ISBN 13: 9781009278164
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 24,21
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. The tension between innovation and financialisation is central to the business corporation. Innovation entails a 'retain-and-reinvest' allocation regime that can form a foundation for stable and equitable economic growth. Driven by shareholder-value ideology, financialisation entails a shift to 'downsize-and-distribute'. This Element investigates this tension in global pharmaceuticals, focusing on the two leading UK companies AstraZeneca and GlaxoSmithKline. In the 2000s both adopted US-style governance, including stock buybacks and stock-based executive pay. Over the past decade, however, first AstraZeneca and then GlaxoSmithKline transitioned to innovation. Critical was the cessation of buybacks to refocus capabilities on investing in an innovative drugs pipeline. Enabling this shift were UK corporate-governance institutions that mitigated US-style shareholder-value maximisation. Reinventing capitalism for the sake of stable and equitable economic growth means eliminating value destruction caused by financialisation and supporting value creation through collective and cumulative innovation. This title is also available as Open Access on Cambridge Core.
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1009278169 ISBN 13: 9781009278164
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 21,88
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: AwesomeBooks, Wallingford, Regno Unito
EUR 19,29
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: Very Good. Investing in Innovation: Confronting Predatory Value Extraction in the U.S. Corporation (Elements in Corporate Governance) This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .
Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
EUR 19,49
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Fine.
Editore: Union for Radical Political Economics, 1974
Da: GuthrieBooks, Spring Branch, TX, U.S.A.
Rivista / Giornale
Single Issue Magazine. Condizione: Good. Paperback. Good. General used condition. Evident wear. Underlining. tight binding.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: California Books, Miami, FL, U.S.A.
EUR 27,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2022
ISBN 10: 1009278169 ISBN 13: 9781009278164
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 25,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press -, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: Bahamut Media, Reading, Regno Unito
EUR 19,29
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press, GB, 2025
ISBN 10: 1009707981 ISBN 13: 9781009707985
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 28,02
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce investments in new drugs. This Element responds to these arguments by showing that pharmaceutical companies (a) should have their drug prices regulated, given scale economies in supplying drugs and price inelasticity of drug demand; (b) use their profits from unregulated drug prices to distribute cash dividends and stock buybacks to shareholders; (c) do not typically rely upon investment by shareholders to fund drug innovation; and (d) benefit from 'collective and cumulative learning' in foundational and translational research that is antecedent and external to their investments in clinical research.
Lingua: Inglese
Editore: URPE - Union for Radical Political Economics, Ann Arbor, MI, 1978
Da: gearbooks, The Bronx, NY, U.S.A.
Soft Cover. Condizione: Very Good. Volume 10, No. 3, Spring 1978. 85 pp. Vol. 10, Number 3, Spring 1978 only! Solidly bound copy with moderate external wear, crisp pages and clean text.
Lingua: Inglese
Editore: Cambridge University Press, GB, 2025
ISBN 10: 1009707981 ISBN 13: 9781009707985
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
EUR 29,48
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce investments in new drugs. This Element responds to these arguments by showing that pharmaceutical companies (a) should have their drug prices regulated, given scale economies in supplying drugs and price inelasticity of drug demand; (b) use their profits from unregulated drug prices to distribute cash dividends and stock buybacks to shareholders; (c) do not typically rely upon investment by shareholders to fund drug innovation; and (d) benefit from 'collective and cumulative learning' in foundational and translational research that is antecedent and external to their investments in clinical research.
Lingua: Inglese
Editore: Oxford University Press (UK), 2019
ISBN 10: 0198846770 ISBN 13: 9780198846772
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Oxford University Press (UK), 2019
ISBN 10: 0198846770 ISBN 13: 9780198846772
Da: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
Hardcover. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Editore: Union for Radical Political Economics
Condizione: Good. Good condition. Volume 6. Number 2. (radical, political science, periodicals) A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.
Lingua: Inglese
Editore: University of Massachusetts Press, Amherst, MA, 2001
ISBN 10: 1558493115 ISBN 13: 9781558493117
Da: PsychoBabel & Skoob Books, Didcot, Regno Unito
EUR 22,47
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. Paperback, with compliments slip from editor Charles Levenstein laid in. Minor pen mark on page block, otherwise very good throughout, with clean, sound pages. TS. Used.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 25,50
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Cambridge University Press, 2023
ISBN 10: 1009410733 ISBN 13: 9781009410731
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.